RxDoctor Payments Data

James Williams, MD

Family Medicine · Newport, TNNPI 1003884412

Payments from drug & device makers

$351in general payments, 2019–2025

Across 22 payments — averaging $15.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$75
  • Lilly USA, LLC$58
  • Amarin Pharma, Inc.$49
  • Philips North America LLC$32
  • Lundbeck LLC$24
  • GSK$20
  • plus $93 from 6 others

What the payments were for

  • Food & beverage$351100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$351 in reported general payments places this provider in the 40th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$72,960
Medicare patients
53
Services billed
1,401

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban91$63,253
Soliqua 100-33Insulin Glargine/Lixisenatide16$23,595
MounjaroTirzepatide13$21,222
JanuviaSitagliptin Phosphate23$20,912
OzempicSemaglutide14$15,057
FarxigaDapagliflozin Propanediol25$14,748
RybelsusSemaglutide12$10,961
Spiriva HandihalerTiotropium Bromide13$10,500
Potassium Chloride87$6,224
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$2,731
Chlorpromazine Hcl11$1,993
Humalog Mix 75-25Insulin Lispro Protamin/Lispro23$1,926
SynthroidLevothyroxine Sodium25$1,801
Clonidine12$1,685
Omeprazole99$1,321

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$18$26,01826 claims
Lilly USA, LLCMounjaro, Humalog Mix 75-25, Insulin Lispro$58$23,65556 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$16$23,59516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Newport

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →